baber/WOPTO huggingface dataset:
Patent NZ-524511-A (NZ)
Title: Use of carnitine for enhancing training-induced bradycardia
Inventor: HARMEYER JOHEIN
IPC: A23K1/18
Filed: 2001-09-18
Abstract: Use of carnitine for achieving or enhancing training-induced bradycardia in a mammal, particularly in a horse, most preferably in a trotter horse, and pharmaceutical or nutritional preparation comprising carnitine is disclosed, wherein bradycardia is a resting period phenomenon, and such resting-period bradycardia results in improved cardiac performance of the equine heart under stress.
Patent NZ-525314-A (NZ)
Title: Method and kit for diagnosing growth hormone dysfunction by determining SNP haplotypes of the proximal promoter region of the gene GH1
Inventor: COOPER DAVID NEIL
IPC: C12Q1/68
Filed: 2003-04-14
Abstract: Described are variants of the human growth factor gene (GH1, located on chromosome 17q23 within a 66 kb cluster of five related genes) and, in particular, variants in the proximal promoter region thereof. Moreover, the interaction of the variants is described and how the interaction affects growth hormone expression. The proximal region of the GH1 gene promoter exhibits a high level of sequence variation in single nucleotides polymorphisms (SNPs) within a 535 base-pair pair stretch. The functional importance of the polymorphic variation has been assessed in both the proximal promoter region and the Locus Control Region (LCR) of the GH1 gene.
Patent NZ-525871-A (NZ)
Title: Use of bisphosphonates for pain treatment
Inventor: FOX ALYSON
IPC: A61K31/66
Filed: 2001-11-27
Abstract: Disclosed is the use of the bisphosphonate zoledronic acid, or a pharmaceutically acceptable salt thereof, or any hydrate thereof in the preparation of a medicament for the treatment of pain associated with osteoporosis, Paget's disease, rheumatoid arthritis or osteoarthritis.
Patent NZ-525956-A (NZ)
Title: Display control system for use with multi-layer displays
Inventor: ENGEL GABRIEL DAMON
IPC: G02B27/22
Filed: 2003-05-16
Abstract: A controller and method for use in a multi-layer display (MLD) is disclosed. The MLD has at least two overlapping display layers. The controller detects when elements on different elements will overlap, and has means for adjusting either the position or visual properties, such as colour or brightness, of one of the elements in order to improve their viewability to a user. This overlapping situation arises, for example, in a GUI when windows displaying text or graphics are positioned over each other.
Patent NZ-526412-A (NZ)
Title: Plant pest and pathogen management with essential oils from plants of Labiatae and Umbellifera families in combination with other control agents
Inventor: TUZUN SADIK
IPC: A01N65/00
Filed: 1999-10-08
Abstract: Disclosed is a composition to repel or kill insects, fungi, nematodes and bacteria, comprising, as an active ingredient, an essential oil or a component thereof, wherein the essential oil or component thereof is derived from at least one plant species in the Family Labiatae and Umbellifera. Also disclosed are methods of protecting a plant against pathogenic or parasitic organisms and preserving food in a container for storage by applying the composition to the plant or food at a concentration of between 1 and 1000 ppm. (62) Divided out of 511021
Patent NZ-529834-A (NZ)
Title: Cytotoxic agents bearing a reactive polyethylene glycol moiety, cytotoxic conjugates comprising polyethylene glycol linking groups, and methods of making and using the same
Inventor: MILLER MICHAEL LOUIS
IPC: A61K47/48
Filed: 2002-09-10
Abstract: Cytotoxic agents of formula (2) bearing a polyethylene glycol (PEG) linking group having a terminal active ester (wherein Z-S is a thiol-containing cytotoxic agent and Q, Y, n and x are as defined in the specification), cytotoxic conjugates comprising one or more cytotoxic agents linked to a cell-binding agent via PEG linking groups, and methods for producing them are disclosed. A therapeutic composition comprising a therapeutically-effective amount of one of these cytotoxic conjugates, and a method of killing selected cell populations comprising contacting target cells, or tissue containing target cells, with an effective amount of one of the cytotoxic conjugates, are also disclosed.
Patent NZ-532815-A (NZ)
Title: Improvements in and relating to storage vessels
Inventor: RAIKES LINCOLN CHARLES
Filed: 2004-05-07
Abstract: A method for the manufacture of storage vessels including the steps of: fabricating a hollow and substantially enclosed cylindrical shape, having a tubular portion and two ends, from metal; constraining the cylindrical shape about each end only; and applying pressure to the interior of the cylindrical shape, the pressure being sufficient to plastically deform the metal and to permanently change at least the shape of the tubular portion of the cylindrical shape to produce a storage vessel that is substantially barrel shaped.
Patent NZ-534874-A (NZ)
Title: Co-therapy for the treatment of migraine comprising a topiramate and a triptan
Inventor: LIVINGSTONE IAN R
IPC: A61K31/343
Filed: 2003-02-25
Abstract: Disclosed herein is a use of a sulfamate compound of formula (I) (such as a topiramate): wherein: X is CH2 or oxygen; R1 is hydrogen or alkyl; and R2, R3, R4 and R5 are as defined in the specification, for the manufacture of a medicament for treating migraine in a subject in need thereof, wherein said medicament further comprises a therapeutically effective amount of a triptan (wherein the triptan may be selected from the group consisting of sumatriptan, naratriptan, rizatriptan, zolmitriptan, eletriptan, frovatriptan and almotriptan), or said medicament is for administration in combination with a therapeutically effective amount of a triptan.
Patent NZ-536514-A (NZ)
Title: Pharmaceutical combination for the treatment of benign prostatic hyperplasia or for the long-term prevention of acute urinary retention
Inventor: BAIKER WOLFGANG
IPC: A61K31/56
Filed: 2003-04-17
Abstract: Disclosed is a pharmaceutical combination comprising the combination of tamsulosin, or an acid addition salt thereof, and finasteride. Combinations of the type disclosed are useful in the treatment of benign prostatic hyperplasia and acute urinary retention.
Patent NZ-537006-A (NZ)
Title: The use of apolipoprotein A-I Milano, for the manufacture ofa composition for treating preventing or reducing ischemic reperfusion injury in a tissue or organ
Inventor: BISGAIER CHARLES L
IPC: A61K38/49
Filed: 2003-05-16
Abstract: Disclosed are methods and compositions for treating or preventing ischemic reperfusion injury in a tissue or organ. The composition is formulated for the administration of apolipoprotein A-I Milano to a corporeal organ or tissue to treat, reduce or prevent ischemic reperfusion injury.
Patent NZ-541550-A (NZ)
Title: Hydrocarbon gas processing
Inventor: CUELLAR KYLE T
IPC: F25J3/02
Filed: 2004-02-12
Abstract: Disclosed is a process for the separation of a gas stream containing methane, C2 components, C3 components, and heavier hydrocarbon components into a volatile residue gas fraction and a relatively less volatile fraction containing a major portion of said C2 components, C3 components, and heavier hydrocarbon components or said C3 components and heavier hydrocarbon components, said process comprising steps wherein: (1) said gas stream is divided into first and second streams; (2) said first stream is cooled to condense substantially all of it and is thereafter expanded to a lower pressure whereby it is further cooled; (3) said expanded cooled first stream is thereafter supplied at a first mid-column feed position to a distillation column; (4) said second stream is expanded to said lower pressure and is supplied to said distillation column at a second mid-column feed position; (5) a vapour distillation stream is withdrawn from a region of said distillation column below said expanded second stream and is cooled sufficiently to condense at least a part of it, thereby forming a residual vapour stream and a condensed stream; (6) at least a portion of said condensed stream is supplied to said distillation column at a top feed position; (7) an overhead vapour stream is withdrawn from an upper region of said distillation column and is directed into heat exchange relation with said vapour distillation stream and heated, thereby to supply at least a portion of the cooling of step (5), and thereafter discharging at least a portion of said heated overhead vapour stream as said volatile residue gas fraction; and (8) the quantities and temperatures of said feed streams to said distillation column are effective to maintain the overhead temperature of said distillation column at a temperature whereby the major portions of the components in said relatively less volatile fraction are recovered.
Patent NZ-541995-A (NZ)
Title: Interlocking block
Filed: 2005-08-25
Abstract: A construction block is provided for use in constructing walls. The block includes a front panel, a rear panel, and at least one web connecting the front and rear panels. Each of the front and rear panels is rectangular and has a top edge surface, a bottom ed ge surface, and right and left edge surfaces. At least one web having top and bottom surface s co-extensive with the top and bottom surfaces of the front and rear panels is provided, thereby to define a top surface of the block, and a bottom surface of the rack. The top surfac e of the block is provided with a shallow rectangular ridge along its length, flanked by longitudinally extending outer support surfaces. The lower surface of the block has a shallow rectangular channel formed therein along its length, flanked by longitudinally extending flat outer foot portions corresponding in width to the outer support surfaces. The right and left edg e surfaces of the front and rear panels are profiled to interfit with one another, whereby the right front edge surface and the left rear edge surface each have a first profile, and the le ft front edge surface and the right rear edge surface each have a second profile, the first and second profiles being complementary to permit blocks to interfit end to end.
Patent NZ-542297-A (NZ)
Title: Somatostatin-dopamine chimeric analogs
Inventor: DONG ZHENG XIN
IPC: A61K/
Filed: 2004-04-08
Abstract: Disclosed is a chimeric analog comprising formula (I), wherein Z is a somatostatin analogue selected from the group consisting of : DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2; Cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)Thr-NH2; DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)Thr-NH2; DTyr-DTyr-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)Thr-NH2; DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2; and DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Thr-Cys)-Thr-NH2; wherein the rest of the substituents are disclosed within the specification; or a pharmaceutically acceptable salt thereof; and wherein each moiety depicted between the brackets is, independently for each occurrence, attached to an N-terminal or an internal amine group or hydroxyl group of Z. Also disclosed is a chimeric analog comprising formula (II) wherein Z is a somatostatin analogue selected from the group listed above for formula (I); wherein the rest of the substituents are disclosed within the specification; or a pharmaceutically acceptable salt thereof; and wherein each moiety depicted between the brackets is independently for each occurrence, attached to an N-terminal or an internal amine group or hydroxyl group of Z
Patent NZ-542843-A (NZ)
Title: Method of manipulating visibility of images on a volumetric display
Inventor: GAO HONGZHI
Filed: 2005-10-05
Abstract: A method of manipulating the visibility of selected target image elements on the screens of a multi-screen display is provided. The method includes the steps of selecting a target element, identifying the screen on which the target element is displayed and the position of the element and manipulating the transparency of the target image element through adjusting its transparency and placing a 'support' image on a different screen of the multi-screen display.
Patent NZ-542955-A (NZ)
Title: At least one macrolide anthelmintic compound and a second anthelmintic agent, such as praziquantel, morantel and/or pyrantel, a non-aqueous solvent and a thickening agent to prevent endo- and ectoparasitic infections
Inventor: SOLL MARK D
IPC: A61K31/365
Filed: 2004-04-05
Abstract: Provided is a spot-on composition comprising at least one of macrocyclic lactone selected from moxidectin, doramectin, emamectin, abamectin, ivermectin, selamectin and eprinomectin and at least one compound selected from praziquantel, morantel and pyrantel, combined with a thickening agent and a non-aqueous solvent and a crystallization inhibitor. Further provided is a method of increasing systemic availability of the composition by administering the composition to a non-human animal.
Patent NZ-550566-A (NZ)
Title: Self-propelled vessel with pump having dual inlets and a single outlet
Inventor: MUIR CALUM BAIRD
Filed: 2006-12-04
Abstract: A vessel has a pump with dual inlets and a single outlet. A power source (typically a diesel engine) is used to provide power to the pump. The vessel is ballasted to float in a body of water and is self-propelled by the pumping system.
Patent NZ-551200-A (NZ)
Title: Method to form a high strength moulded product
Inventor: WONG TECK TIN
IPC: B27N3/04
Filed: 2005-04-01
Abstract: A method to form a high strength moulded product is provided. The method begins by preparing a mouldable composition. The mouldable composition comprises between about 40 to 60 wt % of a fibre mixture and between about 15 to 45 wt % of an adhesive. A mould cavity is loaded with the mouldable composition up to about 90 % of the capacity of the mould cavity before applying a packing pressure of between about 435 to 870 psi to the mouldable composition. A predetermined clearance of between about 0.1 to 0.5 mm is maintained between a first mould part defining the mould cavity and a second mould part. The moulded product is removed from the mould cavity when the mouldable composition is substantially cured.
Patent NZ-561656-A (NZ)
Title: Improved rAAV expression systems for genetic modification of specific capsid proteins
Inventor: WARRINGTON KENNETH H
IPC: C07K14/015
Filed: 2003-05-01
Abstract: Disclosed is a substantially VP2-free rAAV expression system comprising: (a) at least a first rAAV vector that comprises at least a first heterologous nucleic acid segment inserted into the capsid sequence region, said segment encoding at least a first heterologous peptide; and (b) at least a second expression vector that expresses functional VPl and VP3 capsid proteins substantially in the absence of VP2 protein, or at least a second and a third expression vector that separately express functional VPl and VP3 capsid proteins, each substantially in the absence ofVP2 protein.
Patent NZ-566117-A (NZ)
Title: Oral suspension of prednisolone acetate
Inventor: ASOTRA SATISH
IPC: A61K9/00
Filed: 2006-08-03
Abstract: Disclosed is a pharmaceutical composition for oral delivery, comprising a pharmaceutically effective amount of prednisolone acetate particles dispersed in suspension in the composition, wherein the composition is suitable for oral delivery and wherein the prednisolone acetate has a median particle size in the range of about 1 microns to about 30 microns. Also disclosed is the use of said composition in the treatment of endocrine disorders, rheumatic disorders, collagen diseases, dermatologic diseases, allergic states, respiratory diseases, hemaologic disorders, neoplastic diseases, edema, gastrointestinal diseases or nervous diseases.
Patent NZ-566363-A (NZ)
Title: Thread navigation
Inventor: TABOADA ROBERTO C
IPC: G06Q10/06
Filed: 2006-09-08
Abstract: A system for navigating messages within a thread comprises means for accessing the thread; means for determining a location for each message header within the thread; means for modifying an appearance of each message header; means for navigating within the thread using at least one navigational control that is displayed within a message header; and means for rendering the thread. The means for modifying the appearance of each message can comprises changing the shading of each message header. The system can further comprise means for tagging the thread according to an XML schema.
Patent NZ-566913-A (NZ)
Title: A partitioning communication system
Inventor: BECKWITH REYNOLDS WILLIAM
IPC: H04L12/28
Filed: 2006-03-02
Abstract: A communication system is provided. The system includes a plurality of nodes each running a separation kernel (SK) that defines at least one partition on a corresponding node, where the partition on a node communicates data with one or more partitions on another node over one or more communication channels, and a data communication with the partition on the node over the communication channels exhibiting at least one exhibited communication characteristics; and a communication controller that either obscures the exhibited communication characteristics to prevent an illicit flow of information from the partition on the node to a partition on another node or alters the exhibited communication characteristics to limit or eliminate covert channels. A node of the system and a method of communicating data in the system are also provided.
Patent NZ-568880-A (NZ)
Title: A connector
Inventor: LOPES MURRAY GEORGE
IPC: E04H17/16
Filed: 2008-06-06
Abstract: A gate connector includes a main body 2 at least as long as the height of a gate, a set of pintles 3, 4 on which a set of matching gudgeons on a second gate can be hinged, and a set of fasteners 13 such as U bolts to attach the connector to the horizontal frame members of a first gate.
Patent NZ-572986-A (NZ)
Title: 1- [2- (2, 4-dimethylphenylsulfanyl) -phenyl] piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of cognitive impairment
Inventor: FALDT ANDRE
IPC: C07D295/08
Filed: 2007-06-15
Abstract: Disclosed herein is a crystalline form of 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine and pharmaceutically acceptable salts thereof, particularly hydrobromide, hydrochloride, mesylate, fumerate, maleate, meso-tatrate, L-(+)-tatrate, D-(-)-tatrate, sulphate, phosphate or nitrate salts, compositions comprising said crystalline compound, processes for their preparation. Said compounds is useful in the treatment of affect affective disorders; depression, major depressive disorder; postnatal depression; depression associated with bipolar disorder, Alzheimer's disease, psychosis, cancer, age or Parkinson's disease; anxiety; general anxiety disorder; social anxiety disorder; obsessive compulsive disorder; panic disorder; panic attacks; phobia; social phobia; agoraphobia; stress urinary incontinence; emesis; IBS; eating disorders; chronic pain; partial responders; treatment resistant depression; Alzheimer's disease; cognitive impairment; ADHD; melancholia; PTSD; hot flushes; sleep apnea; alcohol, nicotine or carbohydrate craving; substance abuse; or alcohol or drug abuse.
Patent NZ-574119-A (NZ)
Title: Herbicidal composition and method for removing unwanted foliage
Inventor: PENTLAND PHILIP EDWARD
IPC: A01N25/30
Filed: 2007-06-14
Abstract: Disclosed is a method of preparing a spray tank mix of glyphosate comprising: (a) providing glyphosate acid concentrate in the form of solid particulate material of particle size in the range 0.1mm to 5mm; (b) providing an alkaline composition; and (c) forming a mixture of glyphosate acid concentrate and alkaline composition in the spray tank by addition of a composition comprising the glyphosate acid concentrate to a diluted aqueous mixture of the alkaline composition. Also disclosed is method of preparing a spray tank mix of glyphosate comprising: (a) providing a glyphosate acid concentrate in the form of solid particulate material of particle size in the range 0.1 mm to 5mm; (b) providing an alkaline composition; (c) diluting the alkaline composition with water in the spray tank to provide a diluted alkaline mixture; (d) adding a composition comprising the glyphosate acid concentrate, optionally diluted with water, to the dilute alkaline mixture; and (e) optionally adding further water to the spray tank to provide the desired volume. These glyphosate herbicidal formulations are used as weed-killer for removing unwanted foliage.
Patent NZ-582006-A (NZ)
Title: Apparatus for microbiological testing with retention device holding test tube in inverted position within a container
Inventor: BAILEY PETER
IPC: B01L3/14
Filed: 2009-12-15
Abstract: The testing apparatus 500 has a retention device 300 which retains test tube 200 in an inverted position within container 400.
Patent NZ-582486-A (NZ)
Title: Separator device and cleaning system for a stream harvested by a fruit harvesting machine
Inventor: BERTHET JEAN-PAUL
IPC: A23N15/00
Filed: 2008-07-25
Abstract: A device for separating a harvested fruit from other plant material in a crop stream and designed to be mounted in a fruit harvesting machine, comprises a frame 1 and longitudinal separator members 2 that are fastened longitudinally to the frame and spaced transversely from each other to form an array 7, and a conveyor belt that is driven in a longitudinal direction between an upstream roller 4 and a downstream roller 5, where the rollers are fastened to the frame 1. The array separates the crop stream between a portion retained on the array which is mainly other plant material, and a portion passing through the array which is mainly fruit. The belt is positioned under the separator members 2 and provides a space between the belt and the members to receive the portion of the crop stream that passes through the array 7. The belt is provided with teeth 11 which have a base part that extends into the receiving space, and a projecting part 11 b that extends above the separator members 2, and passes through the spaces formed between the members 2. The separator members 2 are fastened, behind the upstream roller 4, by fixing the members to the frame 1 and, in front of the upstream roller, by a rotary member 12 mounted on the frame 1. The member 12 including paddles 13 that are adapted to hold the separator members 2 in position on rotation of the member 12.
Patent NZ-584196-A (NZ)
Title: Local sewage processing unit for extracting water from sewage
Inventor: CREFFIELD ALAN
IPC: E03F3/02
Filed: 2010-03-25
Abstract: Disclosed is a local sewage processing unit. The unit includes: a receiving section configured to receive sewage from a local source of sewage; a processing section configured to extract water from the sewage received at the receiving section, such that the extracted water is non-potable water of sufficient quality that it may be reused without additional controls; and a pump, configured to pump sewage from the receiving section into a sewer network.
Patent NZ-584520-A (NZ)
Title: Sail system including twin mainsails each attached to shroud
Inventor: CARICATO PIETRO
IPC: B63H9/06
Filed: 2008-09-26
Abstract: A sail propulsion system for boats and the like comprises at least one mast (A) located in the longitudinal mid-plane of the boat and a jib (F) controlled by sheets and secured to the head of the mast, as well as at least two mainsails (RS, RD) rove on two shrouds (S) located one to the right and one to the left of the mast and arranged each on a boom (B) mounted on one of said shrouds. This sail system has a greater sail surface with respect to the conventional set of sails consisting of a single mainsail and the relevant jib, whereby with the same wind the sail thrust is greater, moreover the jib and the leeward mainsail meet the wind like a single sail whose efficiency is greater than the efficiency of the two separate sails present in conventional equipments, and finally when sailing before the wind the sail surface has its centre of thrust located on the boat axis so as to make the sailing more stable and less prone to rightward or leftward deviations of the bow, thus increasing safety and allowing to dispense with the use of special sails when sailing before the wind, such as the gennaker or the spinnaker.